FINWIRES · TerminalLIVE
FINWIRES

RPM Beats Fiscal Third-Quarter Estimates, Affirms Sales Growth Expectations

-- RPM International's (RPM) fiscal third-quarter results topped market expectations, while the specialty coatings manufacturer reiterated its sales growth outlook for the ongoing three-month period.

The company on Wednesday reported adjusted earnings of $0.57 per share for the quarter ended Feb. 28, up from last year's $0.35, which was the consensus on FactSet. Sales advanced 8.9% to $1.61 billion, topping the Street's view of $1.55 billion.

The stock jumped 12% in Wednesday trade, taking its year-to-gain 4.8%. RPM is the parent of brands including Varathane, which offers wood-finishing products.

"In a period of volatile market conditions, we generated volume growth and record sales by utilizing our competitive strengths and nimbly focusing on growing end markets," Chief Executive Frank Sullivan said in a statement. "We demonstrated our ability to combine growth with efficiency, leveraging higher volumes to expand margins across all segments."

RPM continues to project fourth-quarter sales to increase by a mid-single digit versus the prior-year period. The Street is looking for $2.17 billion.

"We expect to grow sales and adjusted (earnings before interest and taxes) again in the fourth quarter and deliver record results, even as we face more challenging comparisons and geopolitical uncertainty in the Middle East adds cost and complexity to the operating environment," according to Sullivan.

The US and Iran on Tuesday agreed to a two-week ceasefire. The war, which began at the end of February, spread across the Middle East and curtailed shipments through the crucial Strait of Hormuz, driving up energy prices.

The company is seeking to mitigate higher raw material costs and ensure supply, while implementing pricing actions to offset the remaining cost headwinds, Sullivan said.

In the third quarter, sales in the construction products segment climbed nearly 11% to $546.7 million, driven by the company's North American businesses. The performance coatings division saw revenue increase 8.4% to $496.8 million, while the consumer business improved 7.9% to $564.5 million.

Price: $108.69, Change: $+11.98, Percent Change: +12.39%

相關文章

Asia

企業差旅管理公司預計將衝回至多1.18億英鎊的收入,與先前的業績相比將出現下滑。

根據週三提交給澳洲證券交易所的文件,Corporate Travel Management(ASX:CTD)預計將從2025財年及之前年度的業績中衝回至多1.18億英鎊的收入,高於此前預估的7760萬英鎊。 此前,該公司聘請畢馬威會計師事務所(KPMG)對部分年度的業績進行法務會計審查。畢馬威在審查中發現,該公司在英國已完成的客戶合約和其他收入的確認方面存在一些問題。 該公司表示,根據與部分客戶的商業談判結果,可能需要在上半年業績中衝回至多約1,000萬英鎊的收入。審查證實,部分客戶被收取了高於合約約定的費用。 Corporate Travel Management表示,已對其英國業務進行了“重大調整”,尤其是在財務控制和營運流程方面。該公司還補充說,審查並未在其他地區發現任何問題。 該公司計劃在今年第二季發布經審計的 2025 財年財務報表和經審核的 2026 財年上半年財務報表。

$ASX:CTD
Asia

北方星資源公司3月季度黃金銷售額下降

根據週三提交給澳洲證券交易所的文件,北方星資源公司(ASX:NST)表示,截至2025年3月季度,該公司黃金總銷量為380,807盎司,綜合維持成本(AISC)為每盎司2,709澳元。 先前提交的文件顯示,截至2025年3月季度,該公司黃金總銷量為385,441盎司,綜合維持成本為每盎司2,246澳元。 該公司預計2026財年黃金銷售量將超過150萬盎司,綜合維持成本預計在每盎司2,600澳元至2,800澳元之間。 該公司在支付3.47億澳元現金股利後,淨現金為3.2億澳元,截至3月31日,其現金及貴金屬總持有量為11.8億澳元。 北方之星資源公司(Northern Star Resources)的股價在最近的周三交易中下跌了約2%。

$ASX:NST
Asia

衛材與默克共同進行的腎癌藥物第三期臨床試驗未能達到存活終點

日本製藥公司衛材(Eisai,TYO:4523)和美國默克公司(Merck)的實驗性聯合療法在一項3期臨床試驗中未能達到無惡化存活期和總存活期這兩個主要終點。 根據週二發布的聯合聲明,該試驗旨在評估晚期透明細胞腎細胞癌(一種約佔所有腎癌病例80%的腎癌)的一線治療方案。 LITESPARK-012研究在1688名患者中測試了兩種方案:Keytruda合併Lenvima和Welireg,以及MK-1308A(Keytruda與一種在研抗體的複方製劑)合併Lenvima,並與已確立的Keytruda合併Lenvima方案進行比較。 中期分析顯示,與標準治療相比,兩種實驗性聯合方案均未能達到研究的兩個主要目標,即改善總存活期和無惡化存活期。

$TYO:4523